BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15677518)

  • 1. Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene.
    Weedon MN; Frayling TM; Shields B; Knight B; Turner T; Metcalf BS; Voss L; Wilkin TJ; McCarthy A; Ben-Shlomo Y; Davey Smith G; Ring S; Jones R; Golding J; Byberg L; Mann V; Axelsson T; Syvänen AC; Leon D; Hattersley AT
    Diabetes; 2005 Feb; 54(2):576-81. PubMed ID: 15677518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses.
    Weedon MN; Clark VJ; Qian Y; Ben-Shlomo Y; Timpson N; Ebrahim S; Lawlor DA; Pembrey ME; Ring S; Wilkin TJ; Voss LD; Jeffery AN; Metcalf B; Ferrucci L; Corsi AM; Murray A; Melzer D; Knight B; Shields B; Smith GD; Hattersley AT; Di Rienzo A; Frayling TM
    Am J Hum Genet; 2006 Dec; 79(6):991-1001. PubMed ID: 17186458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites.
    Rose CS; Ek J; Urhammer SA; Glümer C; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabetes; 2005 Oct; 54(10):3026-31. PubMed ID: 16186409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation.
    Spyer G; Macleod KM; Shepherd M; Ellard S; Hattersley AT
    Diabet Med; 2009 Jan; 26(1):14-8. PubMed ID: 19125755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
    Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
    Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women.
    Zaidi FK; Wareham NJ; McCarthy MI; Holdstock J; Kalloo-Hosein H; Krook A; Swinn RA; O'Rahilly S
    Diabet Med; 1997 Mar; 14(3):228-34. PubMed ID: 9088772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
    Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
    PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.
    Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D
    Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men.
    McCarthy MI; Hitman GA; Hitchins M; Riikonen A; Stengård J; Nissinen A; Tuomilehto-Wolf E; Tuomilehto J
    Diabet Med; 1994 Mar; 11(2):198-204. PubMed ID: 8200207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
    Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
    Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity.
    Velho G; Hattersley AT; Froguel P
    Diabetologia; 2000 Aug; 43(8):1060-3. PubMed ID: 10990085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals.
    Freathy RM; Weedon MN; Bennett A; Hypponen E; Relton CL; Knight B; Shields B; Parnell KS; Groves CJ; Ring SM; Pembrey ME; Ben-Shlomo Y; Strachan DP; Power C; Jarvelin MR; McCarthy MI; Davey Smith G; Hattersley AT; Frayling TM
    Am J Hum Genet; 2007 Jun; 80(6):1150-61. PubMed ID: 17503332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
    Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
    Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.